RADIUS acquired by ELSE SOLUTIONS & 21 INVEST

Else Solutions, the Italian manufacturer and distributor of nuclear medicine equipment backed by 21 Invest Healthcare since 2025, acquired the entire share capital of Radius, the Budrio-based distributor of radiotherapy, nuclear medicine and pre-clinical research technologies, from founder and chief executive Mauro Mei. At the time of the deal, Radius generated revenue of €17m and an EBITDA of €0–5M, an EBITDA margin of [members only]. Mauro Mei and Ludovica Mei stayed on to run Radius within the group, and the Mei family reinvested in Else Solutions. The purchase doubled the size of Else Solutions in less than twelve months, taking the combined group to around 70 employees, and fitted a development plan built on a stronger distribution business, growth in radiopharmaceutical handling systems, where the company had its own products and was expanding production capacity, and the international expansion it had begun in 2025. Banco BPM provided the acquisition financing, with Ashurst advising the bank. Else Solutions was advised by GC Advisory as financial adviser, McDermott Will & Schulte on legal and corporate matters, PwC on financial due diligence, Giovannelli & Associati on tax, ERM on ESG and Triadi-Polimi on impact. Mauro Mei and Radius worked with Fineurop Soditic as financial adviser, K-Domus Konsulenza d’Impresa on tax and Studio Bernardini Leoni on legal matters.